High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemiaBing Cui, Thomas J. Kipps, Jian Yu et al.|Blood|2016Cited by 144
Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selectionEmanuela M. Ghia, Thomas J. Kipps, Sonia Jain et al.|Blood|2008Cited by 71
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesElisa ten Hacken, Catherine J. Wu, Rebecca Valentin et al.|JCI Insight|2018Cited by 52